DGX - Quest Diagnostics Incorporated
NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Valuation Measures
| Market Cap (intraday) 5 | 13.83B |
| Enterprise Value 3 | 18.68B |
| Trailing P/E | 19.36 |
| Forward P/E 1 | 15.12 |
| PEG Ratio (5 yr expected) 1 | 2.89 |
| Price/Sales (ttm) | 1.83 |
| Price/Book (mrq) | 2.54 |
| Enterprise Value/Revenue 3 | 2.47 |
| Enterprise Value/EBITDA 6 | 12.61 |
Trading Information
Stock Price History
| Beta (3Y Monthly) | 0.85 |
| 52-Week Change 3 | 2.18% |
| S&P500 52-Week Change 3 | 8.32% |
| 52 Week High 3 | 107.97 |
| 52 Week Low 3 | 78.95 |
| 50-Day Moving Average 3 | 104.69 |
| 200-Day Moving Average 3 | 99.86 |
Share Statistics
| Avg Vol (3 month) 3 | 922.25k |
| Avg Vol (10 day) 3 | 640.64k |
| Shares Outstanding 5 | 134.67M |
| Float | 133.98M |
| % Held by Insiders 1 | 0.35% |
| % Held by Institutions 1 | 91.55% |
| Shares Short (Sep 30, 2019) 4 | 3.94M |
| Short Ratio (Sep 30, 2019) 4 | 4.4 |
| Short % of Float (Sep 30, 2019) 4 | 3.31% |
| Short % of Shares Outstanding (Sep 30, 2019) 4 | 2.93% |
| Shares Short (prior month Aug 30, 2019) 4 | 3.92M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 2.12 |
| Forward Annual Dividend Yield 4 | 2.00% |
| Trailing Annual Dividend Rate 3 | 2.09 |
| Trailing Annual Dividend Yield 3 | 2.00% |
| 5 Year Average Dividend Yield 4 | 1.93 |
| Payout Ratio 4 | 40.50% |
| Dividend Date 3 | Oct 21, 2019 |
| Ex-Dividend Date 4 | Oct 3, 2019 |
| Last Split Factor (new per old) 2 | 1/2 |
| Last Split Date 3 | Jun 21, 2005 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2018 |
| Most Recent Quarter (mrq) | Jun 30, 2019 |
Profitability
| Profit Margin | 9.64% |
| Operating Margin (ttm) | 15.29% |
Management Effectiveness
| Return on Assets (ttm) | 6.43% |
| Return on Equity (ttm) | 13.93% |
Income Statement
| Revenue (ttm) | 7.57B |
| Revenue Per Share (ttm) | 56.09 |
| Quarterly Revenue Growth (yoy) | 1.80% |
| Gross Profit (ttm) | 2.67B |
| EBITDA | 1.48B |
| Net Income Avi to Common (ttm) | 707M |
| Diluted EPS (ttm) | 5.30 |
| Quarterly Earnings Growth (yoy) | 3.20% |
Balance Sheet
| Total Cash (mrq) | 273M |
| Total Cash Per Share (mrq) | 2.03 |
| Total Debt (mrq) | 4.57B |
| Total Debt/Equity (mrq) | 81.86 |
| Current Ratio (mrq) | 0.82 |
| Book Value Per Share (mrq) | 40.44 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.29B |
| Levered Free Cash Flow (ttm) | 616.37M |